Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03407820 · ClinicalTrials.gov registry record · NA
Nylon Versus Chromic Gut Sutures for Minor Hand Surgery
A NA study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
NCT03407820: Completed NA study, sponsored by University of Texas at Austin.
NCT03407820 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 112 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03407820, a NA study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
Study Summary
This study aims to assess the relationship between overall satisfaction with treatment in a group of randomized patients undergoing elective hand surgery using either absorbable (4-0 Chromic) or non-absorbable (5-0 Nylon) sutures. The investigators will also assess factors associated with wound concerns, pain intensity, magnitude of limitations, and physical function within one month of surgery.
Primary Outcome
The scale ranges from 0 to 10, with higher scores representing higher treatment satisfaction.
Interventions
- PROCEDURE Absorbable Chromic gut sutures
- PROCEDURE Non-absorbable Nylon sutures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2018-01-31 |
| Est. Completion | 2022-08-01 |
| Phase | NA |
What the finished NCT03407820 record still lists
NCT03407820 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Absorbable Chromic gut sutures is the first listed.
NCT03407820 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03407820 about?
NCT03407820 is a clinical study titled "Nylon Versus Chromic Gut Sutures for Minor Hand Surgery". This study aims to assess the relationship between overall satisfaction with treatment in a group of randomized patients undergoing elective hand surgery using either absorbable (4-0 Chromic) or non-absorbable (5-0 Nylon) sutures. The investigators will also assess factors associated with wound conc...
What is the current status of trial NCT03407820?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2018-01-31. Estimated completion is 2022-08-01.
What interventions are being tested in trial NCT03407820?
The interventions under investigation include: Absorbable Chromic gut sutures (PROCEDURE), Non-absorbable Nylon sutures (PROCEDURE).
Who is sponsoring clinical trial NCT03407820?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03407820's enrollment target sits among peer trials
112 813th of 2000 higher than 1,185 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI